Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.
about
Targeting the Eph System with Peptides and Peptide ConjugatesHypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells.Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancersImatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine modelsExploring targeted therapy of osteosarcoma using proteomics dataSox9 regulates hyperexpression of Wnt1 and Fzd1 in human osteosarcoma tissues and cells.AMP-Activated Protein Kinase Regulates the Cell Surface Proteome and Integrin Membrane Traffic.miR-181c associates with tumor relapse of high grade osteosarcomaClinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology GroupTumor-suppressing effects of miR451 in human osteosarcoma.Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine originA support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment.A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
P2860
Q26799461-E536ADDB-DFF5-4A43-8B65-CBE08876A619Q27319546-23578FFB-90D3-4AC8-A670-C8D4CA440776Q28082793-1F036FCC-D1BE-4099-9432-9D7F90B52D51Q28540520-50DF6852-DB4E-45CD-BEBB-9F490B9B70BEQ28817274-CDE1EE15-9AF3-4D3D-8703-E2C95C7B6541Q34121370-438CBE69-91DC-4F8B-A6DB-6F864491E012Q35641071-7D42770A-58E0-47B0-B818-FDD67FBC2695Q35987249-227653AD-B514-417B-8924-755BB92FC8A7Q36175120-AA3B9058-E9EF-48AB-92B8-1D8BEAD6AC2BQ39064259-EDD42C3A-48D0-43AC-A43E-96AE83879B34Q41072795-B9FB2943-9F84-4DD8-BACC-D998FA0197A9Q42280200-1F3A04F5-29CE-425C-A3CB-5DBD44235250Q47375034-51DC515D-205C-42DB-A2CD-BD82DAC3C65DQ47900854-29EF1EBF-3B94-4EEC-A09D-26047A1B0FA8
P2860
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Surface proteomic analysis of ...... or for targeted drug delivery.
@en
Surface proteomic analysis of ...... or for targeted drug delivery.
@nl
type
label
Surface proteomic analysis of ...... or for targeted drug delivery.
@en
Surface proteomic analysis of ...... or for targeted drug delivery.
@nl
prefLabel
Surface proteomic analysis of ...... or for targeted drug delivery.
@en
Surface proteomic analysis of ...... or for targeted drug delivery.
@nl
P2093
P2860
P356
P1476
Surface proteomic analysis of ...... or for targeted drug delivery.
@en
P2093
A M Cleton-Jansen
B J van Royen
C R Jiménez
G J L Kaspers
J Posthumadeboer
M A van Geer
M N Helder
P W van Egmond
S R Piersma
P2860
P2888
P304
P356
10.1038/BJC.2013.578
P407
P577
2013-09-24T00:00:00Z